Healthcare Market Research Reports and Trends

Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a  vascular closure device  is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits. The report provides an overall understanding of the market. In this report, the market is segmented on the basis of type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Among these type segment s,  the passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. The access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surgery. The ge

The report  " Health Information Exchange Market  by Set Up Type (Public, Private), Type (Pull, Push), Implementation Model (Federated, Hybrid), Application (Web Portal, Secure Messaging), Solution Type (Portal, Platform Centric), & End Users - Global Forecast to 2020" , analyzes and studies the major market drivers, restraints/challenges, opportunities, key players, competitive landscape, and geographical markets. Browse 78 market data Tables and 41 Figures spread through 201 Pages and in-depth TOC on  "Health Information Exchange Market by Set Up Type (Public, Private), Type (Pull, Push), Implementation Model (Federated, Hybrid), Application (Web Portal, Secure Messaging), Solution Type (Portal, Platform Centric), & End Users - Global Forecast to 2020" https://www.marketsandmarkets.com/Market-Reports/healthcare-information-exchange-market-249987292.html Early buyers will receive 10% customization on reports. The health information exchange mark

The global  tissue diagnostics market  is dominated by North America, followed by Europe.  North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region. The factors such as the high degree of consolidation, the high cost of instruments, and complex regulatory framework for the approval of new products may restrain market growth to a certain extent. Major industry players launched innovative products to maintain and improve their position in the tissue diagnostics market.  Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), and Sakura Finetek Japan (Japan)  have been identified as the key players in this mark

Factors such as the rising companion animal population, increasing demand for pet insurance, and the growth in the number of veterinary practitioners in developed countries are driving the growth of this market. Also, the growing demand for rapid tests and portable instruments for point-of-care services is expected to offer potential growth opportunities for market players in the coming years. However, the increasing pet care costs are expected to restrain market growth to a certain extent. Clinical biochemistry segment to account for the largest share of the  companion animal diagnostics market  in 2019 On the basis of technology, the companion animal diagnostics market is segmented into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics, and other companion animal diagnostic technologies. In 2019, the clinical biochemistry segment is expected to account for the largest share of the companion animal diagnostics market. The higher preference for va

According to the new market research report  “ Companion Diagnostics Market  by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). Don’t miss out on business opportunities in Companion Diagnostics Market.  Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=155571681 A companion diagnostic assay is an in vitro diagnostic device (IVD) that is used to identify whether a patient with certain disease could be benefitted by a particular drug through the biomarker assessment. The report analyzes the companion diagnost

According to the new market research report " Sepsis Diagnostics Market  by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). Don’t miss out on business opportunities in Sepsis Diagnostics Market.  Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=92673155 Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive the demand for sepsis diagnosis

The global In vitro fertilization market is projected to be valued at USD 505.2 Million in 2017 and is expected to grow at a CAGR of 10.9% to reach to USD 847.8 Million by 2022. CooperSurgical (US)  dominated the In vitro fertilization market in 2017. It has a wide product portfolio of IVF media and assisted reproductive technology. The firm offers fertility products which include lab equipment, culture media, and micro tools. These products find applications in hospitals and surgical centers, obstetricians and gynecologists, medical offices, and fertility clinics. To maintain its leading position and increase its customer base in the in vitro fertilization market, the company mainly focuses on expanding its market presence by adopting growth strategies such as acquisitions. For instance in 2016, CooperSurgical acquired Wallace Pharmaceuticals (India) to further strengthen its existing IVF product portfolio. CooperSurgical has its distribution facilities in Connecticut, Texas, and D

The report  “ Blood Collection Market  by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022" , The global blood collection market is expected to reach USD 10.59 Billion by 2022 from USD 8.10 Billion in 2017, at a CAGR of 5.5%. Increasing prevalence of diseases, demand for liquid biopsy, growing demand for blood components, and increasing number of surgeries and accidental cases are the factors driving the growth of the market. Browse 105 Market Data Tables and 29 Figures spread through 133 Pages and in-depth TOC on “Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation, Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User (Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022" Download Free PDF -  https://

The vitamin D therapy market is expected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6%.  Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. The vitamin D therapy market is highly fragmented in nature, with a large number of players offering a variety of products. The major players operating in this market are Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd (India). The key growth strategies followed by most companies in the vitamin D therapy market are agreements & collaborations. These two strategies accounted for the largest

The companion animal diagnostics market is valued at an estimated USD 1.7 billion in 2019 and is projected to grow at a CAGR of 9.8% to reach USD 2.7 billion by 2024. The growing companion animal ownership, rising demand for pet insurance, and the growth in the number of veterinary practitioners in developed countries are the major factors driving the growth of the companion animal diagnostics market. Key players, such as IDEXX Laboratories, Inc. (US) and Zoetis Inc. (US), will continue to dominate this market during the forecast period. The companies adopted new product launches and acquisitions as their major growth strategies to maintain their position in the market. To know about the assumptions considered for the study  download the pdf brochure IDEXX Laboratories, Inc. (US)  dominated the companion animal diagnostics market in 2018. The company has a diversified product portfolio, which includes a wide range of companion animal diagnostic products. IDEXX’s strong positi

The report  “ Fetal (Labor & Delivery) and Neonatal Care Equipment Market  - (Ultrasound, Doppler, Fetal Monitors (Intrapartum, Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy Devices, Ventilator, MRI, CPAP, Capnograph, Resuscitator)-Global Forecast to 2023"  The global fetal and neonatal care equipment market is projected to reach USD 8.4 billion by 2023 from USD 6.4 billion in 2018, at a CAGR of 5.7% during the forecast period Growth in the global fetal and neonatal care equipment market is mainly driven by the huge patient population of preterm and low-weight birth babies in both developed and developing markets, inflow of technologically advanced products, rising awareness across developing nations, and growing number of NICU admissions. Browse 183 market data Tables and 31 Figures spread through 206 Pages and in-depth TOC on “Fetal (Labor & Delivery) and Neonatal Care Equipment Market - (Ultrasound, Doppler, Fetal Monitors (Intrapartum, Antepartum), W

The study estimates the home healthcare size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include expert researchers from homecare service providers, registered nurses, academic research institutes, laboratory technicians, doctors, home healthcare associations, and pathologists. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the home healthcare market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detai